| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/02/2002 | US20020052337 Composition and method for inhibiting platelet aggregation |
| 05/02/2002 | US20020052334 Antisense oligonucleotide, a ribozyme, a protein, a polypeptide, an antibody, or a small molecule. |
| 05/02/2002 | US20020052333 Therapeutic use of cis-element decoys in vivo |
| 05/02/2002 | US20020052331 Of a capped target mRNA; oligonucleoides that inhibit protein translation directly via interference with ribosome assembly. |
| 05/02/2002 | US20020052330 Utilizing SBELEVTM polypeptides and polynucleotides in therapy, and diagnostic assays |
| 05/02/2002 | US20020052329 Lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. |
| 05/02/2002 | US20020052323 Protease inhibitors, particularly for caspase enzyme; treating arthritis, ALS, MS, and the like. |
| 05/02/2002 | US20020052322 Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 05/02/2002 | US20020052321 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/02/2002 | US20020052320 Sustained peptide-release formulation |
| 05/02/2002 | US20020052319 Topical anesthetic/opioid formulations and uses thereof |
| 05/02/2002 | US20020052317 Anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 05/02/2002 | US20020052316 Bax-mediated apoptosis modulating reagents and methods |
| 05/02/2002 | US20020052315 Conformationally constrained backbone cyclized somatostatin analogs |
| 05/02/2002 | US20020052314 Additional smooth muscle relaxant and platelet inhibitory capabilities. |
| 05/02/2002 | US20020052313 Enhances production and affinity of the antibodies in the animal, in response to the vaccine. |
| 05/02/2002 | US20020052312 Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists |
| 05/02/2002 | US20020052311 Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders |
| 05/02/2002 | US20020052310 Bioactive agent in association with a charged lipid wherein the charged lipid has an overall net charge which is opposite to the overall net charge of the agent upon association and wherein release of the agent is sustained. |
| 05/02/2002 | US20020052309 Use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium |
| 05/02/2002 | US20020052308 Nucleic acids, proteins and antibodies |
| 05/02/2002 | US20020052038 Polypeptide for use in the treatment of viral diseases and cancer |
| 05/02/2002 | US20020052035 18891, a novel human lipase |
| 05/02/2002 | US20020052034 Peptide for use in the treatment of pancreatic defects, cardiovascular disorders, eating disorders and tumors |
| 05/02/2002 | US20020052033 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 05/02/2002 | US20020052027 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/02/2002 | US20020052025 RTVP based compositions and methods for the treatment of prostate cancer |
| 05/02/2002 | US20020052020 Novel orphan receptors |
| 05/02/2002 | US20020052019 Nucleotide sequences coding membrane protein for use in diagnostic testing and gene therapy |
| 05/02/2002 | US20020052013 Tumour-specific P450 protein |
| 05/02/2002 | US20020052011 Method for evaluating and affecting male fertility |
| 05/02/2002 | US20020051996 Modular protein libraries and methods of preparation |
| 05/02/2002 | US20020051988 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity |
| 05/02/2002 | US20020051984 Nucleotide sequences coding cell proliferation protein; for use in the treatment of cancer, wounds, inflammation, arthritis, psoraisis, vision and cell proliferation defects |
| 05/02/2002 | US20020051980 Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation |
| 05/02/2002 | US20020051977 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/02/2002 | US20020051976 Methods and compositions for polypeptide engineering |
| 05/02/2002 | US20020051969 Modulatory polypeptide; for use in the treatment of bone disorders |
| 05/02/2002 | US20020051967 Retrovirus; for use as a tool in the diagnosis and prevention of viaral diseases |
| 05/02/2002 | US20020051819 Hexapeptide mixture with antimicrobial activity against Burkholderia cepacia and at least one carrier, effeactive for prevention of growth of Burkholderia cepacia for industrial, pharmeceutical, household and personal care use |
| 05/02/2002 | US20020051818 A core in the form of a tablet and having an enteric coating surrounding core, comprising an acid labile medicament, a binder or filler, a disintegrant and a lubricant, coating is formed of methacrylic acid copolymer and plasticizer |
| 05/02/2002 | US20020051813 Lipomatrix comprises atleast one phospholipid and composed of lipid lattices of stacked bilayers which, when hydrated, form liposomes, useful for producing highly potent vaccines against tumor antigens |
| 05/02/2002 | US20020051808 Drug delivery system involving interaction between protein or polypeptide and hydrophobic biodegradable polymer |
| 05/02/2002 | US20020051792 (CTLA-4, Cytotoxic T-Lymphocyte Antigen-4); vaccines, feline immunomodulators |
| 05/02/2002 | US20020051790 Helicobacter pylori; antigen of given amino acid sequences; superoxide dismutase in the form of a vaccine |
| 05/02/2002 | US20020051784 Methods for modulating T cell unresponsiveness |
| 05/02/2002 | US20020051783 Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means |
| 05/02/2002 | US20020051780 Bind at the same time to the T-cell receptor complex, to tumour- associated antigens on a tumour cell, and, via the Fc portion of the bispecific antibody |
| 05/02/2002 | US20020051778 Method for treatment of malignant neoplasms and a complex preparation having antimalignant activity |
| 05/02/2002 | US20020051777 Method of modulating cellular activity |
| 05/02/2002 | US20020051767 Cancer treatment |
| 05/02/2002 | US20020051765 Method of cancer treatment |
| 05/02/2002 | US20020051763 Recombinant viral genome and nucleic acid sequence, carried by one or two plasmid supports, transcomplementing each other and allowing the host cell to produce defective infectious viruses |
| 05/02/2002 | US20020051760 Method for screening a substance having promoting activity on hair growth |
| 05/02/2002 | EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression. |
| 05/02/2002 | EP1201757A2 Method for preparing water soluble polypeptides |
| 05/02/2002 | EP1201756A2 Method for preparing water soluble polypeptides |
| 05/02/2002 | EP1201754A1 Apoptosis-associated factor |
| 05/02/2002 | EP1201681A1 "Fail" molecules and uses thereof |
| 05/02/2002 | EP1201680A2 Tumor suppressor polypeptide issued from CHC1-L (chromosome condensation 1-like) |
| 05/02/2002 | EP1201679A2 Angiotensin I-converting enzyme inhibitory substance |
| 05/02/2002 | EP1201676A2 PNA-DNA-PNA chimeric macromolecules |
| 05/02/2002 | EP1201249A1 Suspension of EPI-HNE-4, dry powder aerosol derived therefrom, process of preparation thereof, pharmaceutical compositions containing said suspension or aerosol, and their uses |
| 05/02/2002 | EP1201248A2 Combination therapy of angiotensin converting enzyme inhibitor, side-effect reduced amount of aldosterone antagonist and diuretic for treatment of cardiovascular disease |
| 05/02/2002 | EP1201247A2 Treatment of tumor metastases and cancer |
| 05/02/2002 | EP1201246A2 Use of thrombopoietin as a medicament for the therapy and prevention of thrombocytopenia |
| 05/02/2002 | EP1201245A1 Functional oral preparations |
| 05/02/2002 | EP1201231A2 Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticle, and therapeutic agent for treating zinc deficiency |
| 05/02/2002 | EP1201137A1 Cysteine/glycine rich peptides |
| 05/02/2002 | EP1201136A1 Food grade transglutaminase inhibitor and uses thereof |
| 05/02/2002 | EP1200616A2 Enhanced delivery via serpin enzyme complex receptor ligands |
| 05/02/2002 | EP1200608A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 05/02/2002 | EP1200602A1 Dsp-11 dual-specificity map kinase phophatase |
| 05/02/2002 | EP1200596A2 Human synthetases |
| 05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
| 05/02/2002 | EP1200593A2 The il-1l1 gene and polypeptide products |
| 05/02/2002 | EP1200591A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 05/02/2002 | EP1200590A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 05/02/2002 | EP1200589A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 05/02/2002 | EP1200588A1 Single-chain polypeptides comprising troponin i n-terminal fragments and troponin c |
| 05/02/2002 | EP1200587A2 Receptors and associated proteins |
| 05/02/2002 | EP1200586A2 Human nervous system-associated proteins |
| 05/02/2002 | EP1200585A1 T-cell receptor gamma alternate reading frame protein, (tarp) and uses thereof |
| 05/02/2002 | EP1200584A1 Splice variants of cd40-receptor |
| 05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/02/2002 | EP1200581A1 Truncated egf receptor |
| 05/02/2002 | EP1200579A2 Antisense therapy for hormone-regulated tumors |
| 05/02/2002 | EP1200576A2 Dna's encoding proteins with signal peptides |
| 05/02/2002 | EP1200573A1 Antisense modulation of mekk1 expression |
| 05/02/2002 | EP1200570A1 Antisense modulation of p13 kinase p110 delta expression |
| 05/02/2002 | EP1200569A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 05/02/2002 | EP1200560A1 Melanin-concentrating hormone receptor |
| 05/02/2002 | EP1200481A1 A biodegradable polycation composition for delivery of an anionic macromolecule |
| 05/02/2002 | EP1200479A1 Multiple cytokine-antibody complexes |
| 05/02/2002 | EP1200477A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 05/02/2002 | EP1200476A1 Antitumor antibodies, proteins, and uses thereof |
| 05/02/2002 | EP1200474A1 Human g-protein coupled receptor |
| 05/02/2002 | EP1200472A1 Odorant receptors |
| 05/02/2002 | EP1200470A2 Globular assembly of amyloid beta protein and uses thereof |
| 05/02/2002 | EP1200463A2 Antimicrobial histone h1 compositions, kits, and methods of use thereof |